{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:18:01Z","timestamp":1787239081176,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    Increasing availability and utilisation of high-throughput sequencing techniques has resulted in a rapidly expanding range of uterine mesenchymal lesions harbouring recurrent and nonrecurrent gene rearrangements. Within the literature, 3 molecularly confirmed\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    -rearranged uterine corpus tumors have been reported, all representing alveolar rhabdomyosarcomas (ARMS). We report 5 cases of non-ARMS uterine mesenchymal tumors, in patients aged 36 to 71, harbouring novel\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    rearrangements with different fusion partners (\n                    <jats:italic toggle=\"yes\">JRK<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PIK3R4, MEIS1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">ATP7B);<\/jats:italic>\n                    in the fifth case, FISH revealed a\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    gene rearrangement with an unknown fusion partner. Although morphologically heterogenous, all 5 cases had a low-grade spindle cell component with 3 cases showing prominent myxoid stroma. Two cases were originally diagnosed as myxoid leiomyosarcoma, one as high-grade endometrial stromal sarcoma, one as an undifferentiated sarcoma with a fibrosarcoma-like appearance, and the other as a myxoid neoplasm of uncertain malignant potential. In 3 cases, the rearrangements showed similar breakpoints to known recurrent\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    gene fusions; 2 rearrangements (\n                    <jats:italic toggle=\"yes\">JRK::FOXO1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">MEIS1::FOXO1<\/jats:italic>\n                    ) incorporate both an intact transactivation domain and a DNA-binding domain akin to the rearrangements seen in ARMS, likely representing true oncogenic driver events. Although all 5 cases were confined to the uterine corpus at presentation, recurrences occurred in 2 patients indicating a potential for malignant behaviour and justifying the designation of sarcoma. These cases expand the landscape of\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    -rearranged neoplasms and describe a potential new uterine mesenchymal entity. Further study of additional cases is needed to establish whether these rearrangements truly represent an initiating event for a distinct subset of uterine sarcomas, or whether\n                    <jats:italic toggle=\"yes\">FOXO1<\/jats:italic>\n                    rearrangements simply represent an additional noninitiating\/nondriver event within other established tumor types.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002494","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:00:23Z","timestamp":1765371623000},"page":"163-178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Uterine Sarcomas Harbouring Novel FOXO1 Gene Rearrangements"],"prefix":"10.1097","volume":"50","author":[{"given":"Thomas","family":"Pilkington","sequence":"first","affiliation":[{"name":"Department of Pathology, Manchester University NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Watt","sequence":"additional","affiliation":[{"name":"North West Genomics Laboratory Hub, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Dermawan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Haider","sequence":"additional","affiliation":[{"name":"Department of Pathology, Manchester University NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Antonescu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"R1-20260113","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"R2-20260113","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/IGC.0000000000000720","article-title":"Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database","volume":"26","author":"Hosh","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","article-title":"Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms","volume":"32","author":"Croce","year":"2019","journal-title":"Mod Pathol"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/PAS.0000000000001929","article-title":"NTRK-rearranged uterine sarcomas: clinicopathologic features of 15 cases, literature review, and risk stratification","volume":"46","author":"Costigan","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/PAS.0000000000001915","article-title":"Recurrent KAT6B\/A::KANSL1 fusions characterize a potentially aggressive uterine sarcoma morphologically overlapping with low-grade endometrial stromal sarcoma","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5858\/arpa.2023-0324-RA","article-title":"The spectrum of fusions occurring in non-smooth muscle mesenchymal uterine tumors: a review of the current knowledge","volume":"149","author":"Dundr","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","article-title":"Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing","volume":"10","author":"Cheng","year":"2017","journal-title":"BMC Med Genomics"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.3390\/cancers15245892","article-title":"Determinants affecting the clinical implementation of a molecularly informed molecular tumor board recommendation: experience from a tertiary cancer center","volume":"15","author":"T\u00f6gel","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R12-20260113","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"key":"R13-20260113","first-page":"570","article-title":"FoxO1 is a cell-specific core transcription factor for endometrial remodeling and homeostasis during menstrual cycle and early pregnancy","volume":"27","author":"Adiguzel","year":"2021","journal-title":"Hum Reprod Update"},{"key":"R14-20260113","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.4238\/2015.June.18.3","article-title":"FOXO1 is a tumor suppressor in cervical cancer","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet Mol Res"},{"key":"R15-20260113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40478-023-01695-7","article-title":"CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas","volume":"12","author":"Tauzi\u00e8de-Espariat","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep"},{"key":"R17-20260113","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/his.14449","article-title":"Evolving classification of rhabdomyosarcoma","volume":"80","author":"Agaram","year":"2022","journal-title":"Histopathology"},{"key":"R18-20260113","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1073\/pnas.94.15.8047","article-title":"Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma","volume":"94","author":"Davis","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20260113","doi-asserted-by":"crossref","first-page":"300637","DOI":"10.1016\/j.hpr.2022.300637","article-title":"Primary alveolar rhabdomyosarcoma of the uterine corpus expressing MUC4 and OLIG2: a case report with combined morphological and molecular analysis","volume":"28","author":"Nishino","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"R20-20260113","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2018.01.007","article-title":"Uterine rhabdomyosarcoma in adults","volume":"74","author":"Pinto","year":"2018","journal-title":"Hum Pathol"},{"key":"R21-20260113","first-page":"167","article-title":"Advanced alveolar rhabdomyosarcoma of the uterus: a case report","volume":"13","author":"Odoi","year":"2009","journal-title":"Afr J Reprod Health"},{"key":"R22-20260113","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAS.0000000000001196","article-title":"Novel PLAG1 Gene rearrangement distinguishes a subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors","volume":"43","author":"Arias-Stella","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R23-20260113","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41379-021-00744-7","article-title":"Recurrent MEIS1-NCOA2\/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts","volume":"34","author":"Kao","year":"2021","journal-title":"Mod Pathol"},{"key":"R24-20260113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PGP.0000000000000951","article-title":"Uterine MEIS1::NCOA2 fusion sarcoma with lung metastasis: a case report and review of the literature","volume":"43","author":"Xing","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20260113","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/PAS.0000000000002386","article-title":"MEIS1::NCOA1 primitive spindle cell sarcoma of the kidney: report of 7 cases of a distinctive clinicopathologic entity","volume":"49","author":"Argani","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"e70043","DOI":"10.1002\/gcc.70043","article-title":"High-grade uterine sarcoma: first report of a MEIS2::FOXO4 Fusion","volume":"64","author":"Turashvili","year":"2025","journal-title":"Genes Chromosomes Cancer"},{"key":"R28-20260113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-444-63625-6.00003-3","article-title":"The genetics of Wilson disease","volume":"142","author":"Chang","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"R29-20260113","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1078-0432.CCR-24-0148","article-title":"Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma","volume":"30","author":"Dermawan","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R30-20260113","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/his.14292","article-title":"p53 immunohistochemical analysis of fusion-positive uterine sarcomas","volume":"78","author":"Mohammad","year":"2021","journal-title":"Histopathology"},{"key":"R31-20260113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14728222.2013.772136","article-title":"A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma","volume":"17","author":"Olanich","year":"2013","journal-title":"Expert Opin Ther Targets"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:00:22Z","timestamp":1768284022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002494"}},"subtitle":["Report of A Case Series"],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002494","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}